Inhibitory effect of troglitazone on tumor necrosis factor alpha-induced expression of monocyte chemoattractant protein-1 in human mesangial cells (Q28371370)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Inhibitory effect of troglitazone on tumor necrosis factor alpha-induced expression of monocyte chemoattractant protein-1 in human mesangial cells	scientific article

Statements

scholarly article

0 references

Inhibitory effect of troglitazone on tumor necrosis factor alpha-induced expression of monocyte chemoattractant protein-1 in human mesangial cells (English)

0 references

1 reference

based on heuristic

inferred from title

author name string

M Y Ohta

1

0 references

Y Nagai

2

0 references

T Takamura

3

0 references

E Nohara

4

0 references

K Kobayashi

5

0 references

language of work or name

0 references

publication date

February 2000

0 references

0 references

49

0 references

2

0 references

163-6

0 references

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

The prevalence of insulin resistance in kidney disease patients before the development of renal failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

The new oral hypoglycemic agent, CS-045, inhibits the lipid peroxidation of human plasma low density lipoprotein in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

Inhibition of oxidation of low density lipoprotein by troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

Effects of troglitazone and pioglitazone on cytokine-mediated endothelial cell proliferation in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

The role of macrophages in diabetic glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

Monocyte chemoattractant protein-1 in human atheromatous plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

Troglitazone (CS-045) ameliorates albuminuria in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

Activation of nuclear factor-kappa B correlates with MCP-1 expression by human mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

Oxidized lipoproteins found in patients with NIDDM stimulate radical-induced monocyte chemoattractant protein-1 mRNA expression in cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

Establishing the dose response curve for metabolic control with troglitazone, an insulin action enhancer, in type 2 diabetes patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991143-0

7 January 2021

Identifiers

10.1016/S0026-0495(00)91143-0

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28371370&oldid=1667378923"